Gallium-67-citrate scintigraphy of high-grade T-cell non-Hodgkin's lymphoma

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1524-1525

  Lipp, Rainer W ^a,b   Sill, Heinz ^a   Aigner, Reingard ^a   Ranner, Gerhard ^a   Hoefler, Gerald ^a   Passath, Alois ^a   Leb, Georg ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

gallium 67 citrate; non Hodgkin's lymphoma; orbital pseudotumor; scintigraphy

Indexed keywords

GALLIUM CITRATE GA 67;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PRIORITY JOURNAL; PSEUDOTUMOR; T CELL LYMPHOMA; TUMOR SCINTISCANNING;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; CITRATES; CITRIC ACID; GALLIUM RADIOISOTOPES; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; LYMPHOMA, HIGH-GRADE; LYMPHOMA, T-CELL; MALE; ORBITAL NEOPLASMS; TIME FACTORS;

EID: 0029779872     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987;11:445-462.
2. Israel O, Front D, Lam M, et al. Gallium-67 imaging in monitoring lymphoma response to treatment. Cancer 1988;61:2439-2443.
3. Kaplan WD, Jochelson MS, Herman TS, et al. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 1990;8:1966-1970.
4. Front D, Israel O, Epelbaum R, et al. Gallium-67 SPECT before and after treatment of lymphoma. Radiology 1990;175:515-519.
5. Canellos GP. Residual mass in lymphoma may not be residual disease [Editorial]. J Clin Oncol 1988;6:931-932.
6. Rehn S, Nyman R, Glimelius B, Hagberg HE, Sundstrom JC. Non-Hodgkin's lymphoma: predicting prognostic grade with MR imaging. Radiology 1990;176:249 253.
7. Rahmouni A, Tempany C, Jones R, Mann R, Yang A, Zerhouni E. Lymphoma: monitoring tumor size and signal intensity with MR imaging. Radiology 1993;188: 445-451.
8. 67Ga scan in mediastinal malignant lymphoma: a prospective pilot study. Ann Oncol 1994;5: 433-436.
9. Lipp RW, Silly H, Ranner G, et al. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med 1995;36:13-18.
10. Ishii I, Tonami N, Nakajima K, et al. Gallium-67 SPECT in the evaluation of the orbital and ocular mass-like lesions. Nippon Igaku Hoshasen Gakkai Zasshi 1993;53: 688-695.
11. Medeiros LJ, Harris NL. Lymphoid infiltrates of the orbit and conjunctiva. Am J Surg Pathol 1989;13:459-471.
12. Hirasaka T, Sahori A, Inoue M, Morino I, Chaoliang H. A case of primary orbital T-cell lymphoma. Nippon Ganka Gakkai Zasshi 1992;96:1487-1493.